Annual Review Course Webcast (2020)

Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast Only option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.

For the American Board of Urology (ABU) Qualifying (Part 1) Examination, residents need to possess basic urologic knowledge. To fulfill this need, the American Urological Association (AUA) developed this course to disseminate current urologic knowledge and prepare residents for the ABU examination. This course is also of interest to practicing urologists preparing for the ABU Life Long Learning Knowledge Assessment as well as others, including allied health professionals, looking for a thorough review of basic urologic topics.

Webcasts will be available to view on Wednesday, December 9, 2020. 


Registration Fees

Membership Category

Registration Fee

Member$920
Non-Member$1150
Member Resident/Allied$510
Non-Member Resident/Allied$635

 

Target Audience

  • Residents
  • Urologists

Learning Objectives

At the conclusion of this activity, the learner will be able to:

  1. Apply basic, generally accepted urological practices for effective, high-quality patient care.
  2. Demonstrate core knowledge of urology necessary for Part I of the American Board of Urology (ABU) qualifying examination and for the ABU Life Long Learning Knowledge Assessment.
  3. Utilize AUA Guidelines for appropriate patient evaluation and management.
Course summary
Course opens: 
01/08/2020
Course expires: 
12/09/2023
Price:
$1,150.00
Rating: 
0

Annual Review Course

December 3–5, 2020

Scientific Program

SELF STUDY ON-DEMAND MODULES

Anatomy and Embryology

Howard B. Goldman, MD, FACS

  • Applied Anatomy
  • Embryology

Urinary Tract Infection

Michel A. Pontari, MD

Interstitial Cystitis and Sexually Tansmitted Diseases 

Daniel A. Shoskes, MD


FEMALE UROLOGY, URODYNAMICS AND NEUROUROLOGY

Stephen R. Kraus, MD
  • Neurourology
Howard B. Goldman, MD, FACS
  • Overactive Bladder/Urgency Incontinence
  • Stress Urinary Incontinence
  • Pelvic Organ Prolapse
  • Vaginal Masses/Urethral Diverticulum
  • Urinary Fistula
Stephen R. Kraus, MD and Howard B. Goldman, MD, FACS
  • Uroldynamics Tracing Review

BPH

Michel A. Pontari, MD
  • Evaluation
  • Medical Management
  • Surgical Management

RENAL MEDICINE

Daniel A. Shoskes, MD
  • Renal Transplantation
  • Renal Vascular Disease
  • Renal Physiology (including Fluid and Electrolytes)

ADRENAL

Steven J. Shichman, MD
  • Epidemiology, Diagnosis and Imaging (including Cushings, Hyperaldosteronism, Pheochromocytoma, Cancer and the Incidentally Found Adrenal Mass)
  • Management (including Pheochromocytoma, Cancer, Hyperaldosteronism, Incidentaloma and Metastatic Disease)

LAPAROSCOPY

Steven J. Schichman, MD
  • Physiology and Complications

ERECTILE DYSFUNCTION

Akanksha Mehta, MD, MS
  • Physiology of Erection, Pathophysiology of Erectile Dysfunction
  • Evaluation and Management of Erectile Dysfunction
  • Pathophysiology, Evaluation and Management of Priapism
  • Pathophysiology, Evaluation and Management of Peyronie’s Disease

UROLOGIC TRAUMA

Jay Simhan, MD
  • Renal and Ureteral Trauma: Evaluation and Management
  • Bladder and Urethral Trauma: Evaluation and Management
  • Genital Trauma: Evaluation and Management
  • Urethral Stricture Disease

INFERTILITY

Sarah C. Vij, MD
  • Physiology and Pathophysiology of Male Reproduction
  • Evaluation of the Infertile Male
  • Treatment of the Infertile Male (Surgical and Non-surgical)
  • Hypogonadism
  • Testosterone Replacement

UROLITHIASIS (MEDICAL MANAGEMENT)

Sara L. Best, MD
  • Epidemiology, Pathophysiology
  • Evaluation and Medical Management

UROLITHIASIS (SURGICAL MANAGEMENT)

Sara L. Best, MD
  • Surgical Management of Stone Disease

GU RADIOLOGY

Nicole M. Hindman, MD
  • Basics of MR, CT, US, VCUG
  • Solid and Cystic Renal Masses (CT and MR)
  • Transitional Cell Carcinoma
  • Prostate MRI
  • Adrenal Imaging
  • Scrotal Imaging
  • Retroperitoneal Tumors
  • Radiation Basic Principles

PEDIATRIC UROLOGY

Andrew J. Kirsch, MD
  • Congenital Urinary Tract Abnormalities
    • UPJ Obstruction, UVJ Obstruction (megaureter)
    • Ureteroceles
    • Cystic Kidney Disease
    • Posterior Urethral Valves
    • Prune Belly Syndrome
    • Vesicoureteral Reflux
Armando J. Lorenzo, MD, MSc, FRCSC, FAAP, FACS
  • Pediatric Urinary Incontinence and Bladder Disorders
    • Voiding Dysfunction and Neurogenic Bladder
    • Developmental Anomalies of the Bladder
    • Urinary Tract Infection and Secondary Reflux
    • Management of Neurogenic and Non-Neurogenic Bladder
    • Pediatric Metabolic Stones
Andrew J. Kirsch, MD
  • Disorders of the Genitalia/Scrotum
    • Disorders of Sexual Differentiation
    • Hypospadias
    • Undescended Testicle
Armando J. Lorenzo, MD, MSc, FRCSC, FAAP, FACS
  • Pediatric Urological Oncology
    • Wilms’ Tumor and Other Renal Tumors
    • Rhabdomyosarcoma
    • Neuroblastoma
    • Testis Tumors
Andrew J. Kirsch, MD and Armando J. Lorenzo, MD, MSc, FRCSC, FAAP, FACS
  • Pediatric Review Questions

RENAL AND URETERAL TUMORS

Robert G. Uzzo, MD
  • Epidemiology, Anatomy, Diagnosis and Imaging (Including Evaluation of Renal Masses)
    • Treatment of Localized Disease (including Role of Partial Nephrectomy)
    • Treatment of Metastatic Disease
    • Transitional Cell Carcinoma

PROSTATE CANCER

Kristen R. Scarpato, MD, MPH
  • Diagnosis and Screen, Staging, Imaging (including PSA Screening Controversies)
  • Treatment of Localized Cancer (U.S. Stages A and B), Watchful Waiting, Radiation, Interstitial Irradiation, Surgery, Cryosurgery and Hormonal Therapy
  • Treatment of Advanced Cancer (U.S. Stages C and D) and Treatment of Radiation Failure
  • DVT Prophylaxis

PENILE AND URETHRAL CANCER

Robert G. Uzzo, MD
  • Epidemology
  • Diagnosis and Staging
  • Imaging and Treatment

TESTICULAR TUMORS

Kristen R. Scarpato, MD
  • Epidemiology, Diagnosis, Staging and Imaging (including the Role of Markers and CIS)
    • Treatment of Seminoma
    • Treatment of Non-Seminomatous Germ Cell Tumors (including Controversy Regarding Stage A Management, Risk Factors for Recurrence, Algorithms for Stages A,B, and C)

BLADDER CANCER

Michael A. O'Donnell, MD
  • Epidemiology, Anatomy, Diagnosis and Imaging
  • Treatment of NMIBC/ Superficial Disease Managment
  • Bladder Cancer Test Questions
Angela M. Smith, MD, MS, FACS
  • Staging and Risk Stratification of Muscle Invasive Bladder Cancer
  • Multidisciplinary Treatment including Radical Cystectomy, Lymphadenectomy, Peri-Operative Chemotherapy and Chemoradiation Therapy
  • Metabolic Derangements that Occur with Diversions
  • Other Bladder Sparing Treatments
  • Treatment of Metastatic Disease
  • Bladder Cancer Test Questions

METHOD OF PARTICIPATION: 

Learners will participate in this online educational activity by taking the pre-test, viewing the webcast and completing the post-test and evaluation. To claim CME credit for this enduring material, learners must complete the post-test, passing with 80% accuracy and submit the program evaluation.

Estimated time to complete this activity: 26.50 hours

Release Date: December, 2020
Expiration Date: December, 2023

ACCREDITATION: 

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: 

The American Urological Association designates this enduring material for a maximum of 26.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER LEARNERS: 

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

EVIDENCE BASED CONTENT: 

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA DISCLOSURE POLICY: 

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST: 

All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES: 

The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

 
Status
Price
Title
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.

Price

Price:
$1,150.00
Please login or register to take this course.

AUA Members save 25%!  For more information on membership benefits, visit www.AUAnet.org/Join

Webcast Pricing:

Membership Category

Registration Fee

Member$920
Non-Member$1150
Member Resident/Allied$510
Non-Member Resident/Allied$635

 

Webcasts will be available to view on Wednesday, December 9, 2020.


Cancellation Policy

Live Course: An administrative fee of 15% is assessed if registration is cancelled up to six weeks prior to the course. If registration is cancelled four to six weeks from the course, the cancellation fee is 50% of the registration fee paid. No registration fees will be refunded less than four weeks prior to the course. In the event the Live Course converts from live in-person to a live virtual course, all registrations will be converted to the live virtual course and no refunds will be issued.  The AUA will not refund individual airline tickets or travel costs. The AUA will not refund hotel costs for arrangements made OUTSIDE of the AUA's Block or housing arrangements booked outside of the AUA Headquarter Hotel.

Printed syllabi will only be provided for a live in-person course.  In the event of a live virtual course, no printed syllabi will be shipped and a refund in the amount paid for the syllabus will be issued.

Webcast: Cancellations must be made no later than one week prior to the live course. Subscription fees will not be refunded after the cancellation period. Purchases after the live course date are not eligible for a refund.

Registration Transfer: Customers switching from an option of lesser value to a higher value will be required to pay the difference in cost between the two options. Switching to an option of lesser value from a higher value must be made no later than six weeks prior to the course and will be subject to an administrative fee of 15% of the cost of the course from which they are transferring. Transfer of registration from a higher value option to an option of lesser value past six weeks prior to the course will not receive a refund.

Cancellations must be made in writing. Requests may be made via mail or fax to 410-689-3912. Questions? Call 1-800-908-9414 or email registration@AUAnet.org.

AUA Education & Research reserves the right to cancel this course if a minimum enrollment is not reached before October 29, 2020. If AUA Education & Research cancels this course, registration fees will be refunded in full and notification will be sent by November 5, 2020.


Attendee Information & Policies 

Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the American Urological Association (AUA). 

Consent to Use of Photographic Images: Registration and attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the registrant or attendee's image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities. 

 Audio, Video, Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms. 

Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the AUA. 

Special Assistance/Dietary Needs: The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.